Author(s): Dharmendra Singh Sisodiya, Anuraj Soni, Ronak Patel, Uma Sankar Rao Majji, Praveen Khirwadkar

Email(s): ds.sisodiya27@gmail.com

DOI: Not Available

Address: Dharmendra Singh Sisodiya*, Anuraj Soni, Ronak Patel, Uma Sankar Rao Majji, Praveen Khirwadkar
B.N. College of Pharmacy, Udaipur (Raj.)
*Corresponding Author

Published In:   Volume - 5,      Issue - 5,     Year - 2012


ABSTRACT:
Oseltamivir phosphate is used in the treatment and prophylaxis of both influenza A and influenza B. Oseltamivir is readily absorbed from the gastrointestinal tract after oral administration of oseltamivir phosphate and is extensively converted predominantly by hepatic esterases to oseltamivir phosphate. At least 75% of an oral dose reaches the systemic circulation as oseltamivir phosphate. Exposure to oseltamivir is less than 5% of the total exposure after oral dosing. So in oral dosage form it give high bioavability. A wide choice of vehicles ranging for oral suspension development .for a good dosage form must important of choosing of a good vehicle.


Cite this article:
Dharmendra Singh Sisodiya, Anuraj Soni, Ronak Patel, Uma Sankar Rao Majji, Praveen Khirwadkar. Formulation and Evaluation of Oral Suspension of Oseltamivir Phosphate Using Different Vehicle. Research J. Pharm. and Tech. 5(5): May2012; Page 635-640.

Cite(Electronic):
Dharmendra Singh Sisodiya, Anuraj Soni, Ronak Patel, Uma Sankar Rao Majji, Praveen Khirwadkar. Formulation and Evaluation of Oral Suspension of Oseltamivir Phosphate Using Different Vehicle. Research J. Pharm. and Tech. 5(5): May2012; Page 635-640.   Available on: https://rjptonline.org/AbstractView.aspx?PID=2012-5-5-2


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available